Estrella Immunopharma (ESLA) vs Jasper Therapeutics (JSPR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Estrella Immunopharma (ESLA) has outperformed Jasper Therapeutics (JSPR) over the past year, losing 67.9% versus a loss of 76.7%. Over five years, ESLA leads with a -95.8% price change compared with -99.7% for JSPR. Jasper Therapeutics is the larger company by market cap ($18.6 million vs $18.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ESLA | JSPR |
|---|---|---|
| Share price | $0.4175 | $0.56 |
| Market cap | $18.16M | $18.63M |
| 1-day change | -0.43% | -1.70% |
| YTD return | -73.24% | -69.40% |
| 1-year return | -67.88% | -76.67% |
| 5-year return | -95.77% | -99.66% |
| EPS (TTM) | $-0.25 | $-1.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.15 | $2.69 |
| 52-week low | $0.3611 | $0.315 |
| Distance from 52-week high | -86.75% | -79.18% |
| Average volume | 38.27K | 1.37M |
| Shares outstanding | 43.50M | 33.27M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ESLA vs JSPR FAQ
Which is bigger, Estrella Immunopharma or Jasper Therapeutics?
Jasper Therapeutics (JSPR) is larger, with a market capitalization of $18.63M compared with $18.16M for Estrella Immunopharma (ESLA).
Which stock has performed better over the past year, ESLA or JSPR?
ESLA returned -67.88% over the past 12 months, compared with -76.67% for JSPR (price return, excluding dividends). Past performance does not predict future results.
Are Estrella Immunopharma and Jasper Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.